Showing 101 - 120 results of 371 for search '"vaccine"', query time: 0.09s Refine Results
  1. 101
  2. 102
  3. 103

    Saccharomyces Boulardii and Saccharomyces Cerevisiae Improve Immunity in Broilers Vaccinated Against Pasteurella Multocida and Salmonella Gallinarum by C Von Mühlen, NL Conrad, AP Roll, RC Dias, FPL Leite, CD Corcini, AS Varela Junior, VFB Roll

    Published 2025-02-01
    “…A total of 105 male Cobb 500 broilers were divided into four groups: T1 (vaccinated, no supplement, n = 30), T2 (vaccinated, S. boulardii supplement, n = 30), T3 (vaccinated, S. cerevisiae supplement, n = 30), and T4 (non-vaccinated, no supplement, n = 15). …”
    Get full text
    Article
  4. 104
  5. 105

    PROTACs: Mechanism and Bioavailability enhancement strategies by nanotechnology, RNA viral infections (vaccine strategy) and Prodrug development by Sanaul Mustafa, Md Sabir Hussain Siddiquee

    Published 2025-01-01
    “…Moreover, arguably the most interesting virtue of PROTACs is its applicability for RNA viral infections (new vaccine design) based on the degradation of viral proteins. …”
    Get full text
    Article
  6. 106
  7. 107
  8. 108

    Potential public health impacts of gonorrhea vaccination programmes under declining incidences: A modeling study. by Lin Geng, Lilith K Whittles, Borame L Dickens, Martin T W Chio, Yihao Chen, Rayner Kay Jin Tan, Azra Ghani, Jue Tao Lim

    Published 2025-02-01
    “…We explored the efficacy of implementing six vaccination programmes: (1) offering vaccination to all male adolescents in schools (vaccination before entry [VbE]), (2) offering vaccination to individuals attending sexual health clinics for testing (vaccination on attendance [VoA]), (3) offering vaccination to individuals attending sexual health clinics and who were diagnosed with gonorrhea (vaccination on diagnosis [VoD]), or (4) vaccination according to risk (VaR), by offering vaccination to patients who were diagnosed with gonorrhea plus individuals who tested negative, but report having more than five sexual partners per year. …”
    Get full text
    Article
  9. 109
  10. 110
  11. 111

    Uptake, safety and effectiveness of inactivated influenza vaccine in inflammatory bowel disease: a UK-wide study by Abhishek Abhishek, Christian D Mallen, Georgina Nakafero, Matthew J Grainge, Tim Card, Jonathan S Nguyen Van-Tam

    Published 2024-05-01
    “…To investigate vaccine effectiveness, we calculated the propensity score (PS) for vaccination and conducted Cox proportional hazard regression with inverse-probability treatment weighting on PS. …”
    Get full text
    Article
  12. 112

    Assessment of Management Factors Influencing Vaccination Against Cholera in the Health District of Katana, the Democratic Republic of the Congo by Irène Ntererwa-Nsimire, Leonid M Irenge, Paulin B Mutombo, Eric M Mafuta, Jean-Luc Gala, Dosithée Ngo-Bebe

    Published 2025-02-01
    “…Cholera vaccine for children under 2 years was available in all the 5 health areas investigated, only 2 out of 5 health areas had enough vaccine stockpiles. …”
    Get full text
    Article
  13. 113
  14. 114
  15. 115
  16. 116
  17. 117
  18. 118
  19. 119
  20. 120

    The immunogenicity of PRV ΔgE/TK/UL49.5 three-gene-deleted vaccine in mice by Chenmeng Ding, Yawei Sun, Xianfeng Zhang, Mengmeng Shi, Han Yang, Xin Zhou, Shuangshuang Li, Yongtao Li, Xia Yang, Linyang Yu, Lu Chen

    Published 2025-02-01
    “…Abstract Background Pseudorabies (PR) caused by the re-emerging of pseudorabies virus (PRV) variant has outbroken among PRV vaccine immunized swine in many pig farms, which has caused serious social and economic consequences since the end of 2011. …”
    Get full text
    Article